Immune cells from your own tumor could fight advanced cancer
NCT ID NCT07294872
First seen Jan 03, 2026 · Last updated May 06, 2026 · Updated 24 times
Summary
This early-stage study tests a personalized cell therapy called TIL (tumor-infiltrating lymphocytes) for people with advanced solid tumors that haven't responded to standard treatments. Doctors take immune cells from a patient's own tumor, grow them in a lab, and give them back through an IV. The goal is to see if this approach is safe and can shrink tumors. About 30 adults aged 18 to 75 will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sichuan Cancer Hospital & Institute, Sichuan Cancer Center
Chengdu, China
Conditions
Explore the condition pages connected to this study.